1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J-D, Coopersmith CM et al: The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). Jama 2016, 315(8):801.
2. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. The New England journal of medicine 2003, 348(16):1546-1554.
3. Darbà J, Marsà A: Epidemiology, management and costs of sepsis in Spain (2008-2017): a retrospective multicentre study. Current medical research and opinion 2020, 36(7):1089-1095.
4. Tian HC, Zhou JF, Weng L, Hu XY, Peng JM, Wang CY, Jiang W, Du XP, Xi XM, An YZ et al: Epidemiology of Sepsis-3 in a sub-district of Beijing: secondary analysis of a population-based database. Chinese medical journal 2019, 132(17):2039-2045.
5. Almog Y: Statins, inflammation, and sepsis: hypothesis. Chest 2003, 124(2):740-743.
6. Huang M, Cai S, Su J: The Pathogenesis of Sepsis and Potential Therapeutic Targets. Int J Mol Sci 2019, 20(21).
7. Cecconi M, Evans L, Levy M, Rhodes A: Sepsis and septic shock. Lancet (London, England) 2018, 392(10141):75-87.
8. Dhainaut JF, Tenaillon A, Hemmer M, Damas P, Le Tulzo Y, Radermacher P, Schaller MD, Sollet JP, Wolff M, Holzapfel L et al: Confirmatory platelet-activating factor receptor antagonist trial in patients with severe gram-negative bacterial sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. BN 52021 Sepsis Investigator Group. Crit Care Med 1998, 26(12):1963-1971.
9. O'Brien JM, Jr., Abraham E: Human models of endotoxemia and recombinant human activated protein C. Crit Care Med 2004, 32(5 Suppl):S202-208.
10. Xiao SH, Luo L, Liu XH, Zhou YM, Liu HM, Huang ZF: Curative efficacy and safety of traditional Chinese medicine xuebijing injections combined with ulinastatin for treating sepsis in the Chinese population: A meta-analysis. Medicine 2018, 97(23):e10971.
11. Kwak B, Mulhaupt F, Myit S, Mach F: Statins as a newly recognized type of immunomodulator. Nature medicine 2000, 6(12):1399-1402.
12. Liao JK, Laufs U: Pleiotropic effects of statins. Annual review of pharmacology and toxicology 2005, 45:89-118.
13. Jain MK, Ridker PM: Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nature reviews Drug discovery 2005, 4(12):977-987.
14. Wenner Moyer M: The search beyond statins. Nature medicine 2010, 16(2):150-153.
15. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM et al: 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 2014, 63(25 Pt B):2889-2934.
16. Terblanche M, Almog Y, Rosenson RS, Smith TS, Hackam DG: Statins and sepsis: multiple modifications at multiple levels. The Lancet Infectious Diseases 2007, 7(5):358-368.
17. Donnino MW, Cocchi MN, Howell M, Clardy P, Talmor D, Cataldo L, Chase M, Al-Marshad A, Ngo L, Shapiro NI: Statin therapy is associated with decreased mortality in patients with infection. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2009, 16(3):230-234.
18. Dobesh PP, Klepser DG, McGuire TR, Morgan CW, Olsen KM: Reduction in mortality associated with statin therapy in patients with severe sepsis. Pharmacotherapy 2009, 29(6):621-630.
19. Janda S, Young A, Fitzgerald JM, Etminan M, Swiston J: The effect of statins on mortality from severe infections and sepsis: a systematic review and meta-analysis. Journal of critical care 2010, 25(4):656.e657-622.
20. Tleyjeh IM, Kashour T, Hakim FA, Zimmerman VA, Erwin PJ, Sutton AJ, Ibrahim T: Statins for the prevention and treatment of infections: a systematic review and meta-analysis. Archives of internal medicine 2009, 169(18):1658-1667.
21. Patel JM, Snaith C, Thickett DR, Linhartova L, Melody T, Hawkey P, Barnett AH, Jones A, Hong T, Cooke MW et al: Randomized double-blind placebo-controlled trial of 40 mg/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial). Crit Care 2012, 16(6):R231.
22. Niessner A, Steiner S, Speidl WS, Pleiner J, Seidinger D, Maurer G, Goronzy JJ, Weyand CM, Kopp CW, Huber K et al: Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo. Atherosclerosis 2006, 189(2):408-413.
23. Morandi A, Hughes CG, Thompson JL, Pandharipande PP, Shintani AK, Vasilevskis EE, Han JH, Jackson JC, Laskowitz DT, Bernard GR et al: Statins and delirium during critical illness: a multicenter, prospective cohort study. Crit Care Med 2014, 42(8):1899-1909.
24. Page VJ, Casarin A, Ely EW, Zhao XB, McDowell C, Murphy L, McAuley DF: Evaluation of early administration of simvastatin in the prevention and treatment of delirium in critically ill patients undergoing mechanical ventilation (MoDUS): a randomised, double-blind, placebo-controlled trial. The Lancet Respiratory Medicine 2017, 5(9):727-737.
25. MIMIC-IV v1.0 [https://mimic.physionet. org/]
26. Khwannimit B, Bhurayanontachai R, Vattanavanit V: Validation of the Sepsis Severity Score Compared with Updated Severity Scores in Predicting Hospital Mortality in Sepsis Patients. Shock 2017, 47(6):720-725.
27. Liu Z, Meng Z, Li Y, Zhao J, Wu S, Gou S, Wu H: Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with Sepsis. Scandinavian journal of trauma, resuscitation and emergency medicine 2019, 27(1):51.
28. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Medical care 2005, 43(11):1130-1139.
29. Wiewel MA, Scicluna BP, van Vught LA, Hoogendijk AJ, Zwinderman AH, Lutter R, Horn J, Cremer OL, Bonten MJ, Schultz MJ et al: The host response in critically ill sepsis patients on statin therapy: a prospective observational study. Annals of intensive care 2018, 8(1):9.
30. Mansur A, Steinau M, Popov AF, Ghadimi M, Beissbarth T, Bauer M, Hinz J: Impact of statin therapy on mortality in patients with sepsis-associated acute respiratory distress syndrome (ARDS) depends on ARDS severity: a prospective observational cohort study. BMC medicine 2015, 13:128.
31. Aznaouridis K, Masoura C, Vlachopoulos C, Tousoulis D: Statins in Stroke. Curr Med Chem 2019, 26(33):6174-6185.
32. Li J, Li JJ, He JG, Nan JL, Guo YL, Xiong CM: Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway. Cardiovascular therapeutics 2010, 28(1):8-14.
33. Hackam DG, Mamdani M, Li P, Redelmeier DA: Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet (London, England) 2006, 367(9508):413-418.
34. Almog Y, Novack V, Eisinger M, Porath A, Novack L, Gilutz H: The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases. Crit Care Med 2007, 35(2):372-378.
35. Pertzov B, Eliakim-Raz N, Atamna H, Trestioreanu AZ, Yahav D, Leibovici L: Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults - A systematic review and meta-analysis. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2019, 25(3):280-289.
36. Chen M, Ji M, Si X: The effects of statin therapy on mortality in patients with sepsis: A meta-analysis of randomized trials. Medicine 2018, 97(31):e11578.
37. Thomas G, Hraiech S, Loundou A, Truwit J, Kruger P, McAuley DF, Papazian L, Roch A: Statin therapy in critically-ill patients with severe sepsis: a review and meta-analysis of randomized clinical trials. Minerva anestesiologica 2015, 81(8):921-930.
38. Kruger PS, Harward ML, Jones MA, Joyce CJ, Kostner KM, Roberts MS, Venkatesh B: Continuation of statin therapy in patients with presumed infection: a randomized controlled trial. Am J Respir Crit Care Med 2011, 183(6):774-781.
39. Oh TK, Song IA, Choi S: Prior statin therapy and mortality among critically ill patients: a systemic review and meta-analysis of cohort studies. Annals of translational medicine 2020, 8(6):396.
40. Almog Y, Shefer A, Novack V, Maimon N, Barski L, Eizinger M, Friger M, Zeller L, Danon A: Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation 2004, 110(7):880-885.
41. Kruger P, Fitzsimmons K, Cook D, Jones M, Nimmo G: Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive Care Med 2006, 32(1):75-79.
42. Atterton B, Paulino MC, Povoa P, Martin-Loeches I: Sepsis Associated Delirium. Medicina (Kaunas, Lithuania) 2020, 56(5).
43. Ebersoldt M, Sharshar T, Annane D: Sepsis-associated delirium. Intensive Care Med 2007, 33(6):941-950.